Agilent Technologies Inc. (A) , Human Metabolome Technologies To Co-develop Metabolomics Solution For Disease And Drug Research
10/19/2005 5:09:19 PM
Tokyo (JCNN) - On June 20, Agilent Technologies and Human Metabolome Technologies (HMT) announced that they have reached an agreement to collaborate in developing an integrated solution for metabolome analysis.
Under the terms of the agreement, the two companies will combine HMT's biochemical assays with Agilent's capillary electrophoresis (CE) and mass spectrometry (MS) technologies, and develop a new solution that will be able to profile, identify and determine the quantity of metabolic markers.
comments powered by